To investigate the role of Hsp70 expression in developing resistance to paclitaxel, siRNA knockdown in chronic myeloid leukemia cell lines was performed, leading to a reduction of cytoplasmic Hsp70 levels by 50%. Here, HSPA4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.